Literature DB >> 28444987

Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Agostino Colli1, Juan Cristóbal Gana2, Jason Yap3, Thomasin Adams-Webber4, Natalie Rashkovan5, Simon C Ling6, Giovanni Casazza7.   

Abstract

BACKGROUND: Current guidelines recommend screening of people with oesophageal varices via oesophago-gastro-duodenoscopy at the time of diagnosis of hepatic cirrhosis. This requires that people repeatedly undergo unpleasant invasive procedures with their attendant risks, although half of these people have no identifiable oesophageal varices 10 years after the initial diagnosis of cirrhosis. Platelet count, spleen length, and platelet count-to-spleen length ratio are non-invasive tests proposed as triage tests for the diagnosis of oesophageal varices.
OBJECTIVES: Primary objectives To determine the diagnostic accuracy of platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices of any size in paediatric or adult patients with chronic liver disease or portal vein thrombosis, irrespective of aetiology. To investigate the accuracy of these non-invasive tests as triage or replacement of oesophago-gastro-duodenoscopy. Secondary objectives To compare the diagnostic accuracy of these same tests for the diagnosis of high-risk oesophageal varices in paediatric or adult patients with chronic liver disease or portal vein thrombosis, irrespective of aetiology.We aimed to perform pair-wise comparisons between the three index tests, while considering predefined cut-off values.We investigated sources of heterogeneity. SEARCH
METHODS: The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Hepato-Biliary Group Diagnostic Test Accuracy Studies Register, the Cochrane Library, MEDLINE (OvidSP), Embase (OvidSP), and Science Citation Index - Expanded (Web of Science) (14 June 2016). We applied no language or document-type restrictions. SELECTION CRITERIA: Studies evaluating the diagnostic accuracy of platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices via oesophago-gastro-duodenoscopy as the reference standard in children or adults of any age with chronic liver disease or portal vein thrombosis, who did not have variceal bleeding. DATA COLLECTION AND ANALYSIS: Standard Cochrane methods as outlined in the Cochrane Handbook for Diagnostic Test of Accuracy Reviews. MAIN
RESULTS: We included 71 studies, 67 of which enrolled only adults and four only children. All included studies were cross-sectional and were undertaken at a tertiary care centre. Eight studies reported study results in abstracts or letters. We considered all but one of the included studies to be at high risk of bias. We had major concerns about defining the cut-off value for the three index tests; most included studies derived the best cut-off values a posteriori, thus overestimating accuracy; 16 studies were designed to validate the 909 (n/mm3)/mm cut-off value for platelet count-to-spleen length ratio. Enrolment of participants was not consecutive in six studies and was unclear in 31 studies. Thirty-four studies assessed enrolment consecutively. Eleven studies excluded some included participants from the analyses, and in only one study, the time interval between index tests and the reference standard was longer than three months. Diagnosis of varices of any size. Platelet count showed sensitivity of 0.71 (95% confidence interval (CI) 0.63 to 0.77) and specificity of 0.80 (95% CI 0.69 to 0.88) (cut-off value of around 150,000/mm3 from 140,000 to 150,000/mm3; 10 studies, 2054 participants). When examining potential sources of heterogeneity, we found that of all predefined factors, only aetiology had a role: studies including participants with chronic hepatitis C reported different results when compared with studies including participants with mixed aetiologies (P = 0.036). Spleen length showed sensitivity of 0.85 (95% CI 0.75 to 0.91) and specificity of 0.54 (95% CI 0.46 to 0.62) (cut-off values of around 110 mm, from 110 to 112.5 mm; 13 studies, 1489 participants). Summary estimates for detection of varices of any size showed sensitivity of 0.93 (95% CI 0.83 to 0.97) and specificity of 0.84 (95% CI 0.75 to 0.91) in 17 studies, and 2637 participants had a cut-off value for platelet count-to-spleen length ratio of 909 (n/mm3)/mm. We found no effect of predefined sources of heterogeneity. An overall indirect comparison of the HSROCs of the three index tests showed that platelet count-to-spleen length ratio was the most accurate index test when compared with platelet count (P < 0.001) and spleen length (P < 0.001). Diagnosis of varices at high risk of bleeding. Platelet count showed sensitivity of 0.80 (95% CI 0.73 to 0.85) and specificity of 0.68 (95% CI 0.57 to 0.77) (cut-off value of around 150,000/mm3 from 140,000 to 160,000/mm3; seven studies, 1671 participants). For spleen length, we obtained only a summary ROC curve as we found no common cut-off between studies (six studies, 883 participants). Platelet count-to-spleen length ratio showed sensitivity of 0.85 (95% CI 0.72 to 0.93) and specificity of 0.66 (95% CI 0.52 to 0.77) (cut-off value of around 909 (n/mm3)/mm; from 897 to 921 (n/mm3)/mm; seven studies, 642 participants). An overall indirect comparison of the HSROCs of the three index tests showed that platelet count-to-spleen length ratio was the most accurate index test when compared with platelet count (P = 0.003) and spleen length (P < 0.001). DIagnosis of varices of any size in children. We found four studies including 277 children with different liver diseases and or portal vein thrombosis. Platelet count showed sensitivity of 0.71 (95% CI 0.60 to 0.80) and specificity of 0.83 (95% CI 0.70 to 0.91) (cut-off value of around 115,000/mm3; four studies, 277 participants). Platelet count-to-spleen length z-score ratio showed sensitivity of 0.74 (95% CI 0.65 to 0.81) and specificity of 0.64 (95% CI 0.36 to 0.84) (cut-off value of 25; two studies, 197 participants). AUTHORS'
CONCLUSIONS: Platelet count-to-spleen length ratio could be used to stratify the risk of oesophageal varices. This test can be used as a triage test before endoscopy, thus ruling out adults without varices. In the case of a ratio > 909 (n/mm3)/mm, the presence of oesophageal varices of any size can be excluded and only 7% of adults with varices of any size would be missed, allowing investigators to spare the number of oesophago-gastro-duodenoscopy examinations. This test is not accurate enough for identification of oesophageal varices at high risk of bleeding that require primary prophylaxis. Future studies should assess the diagnostic accuracy of this test in specific subgroups of patients, as well as its ability to predict variceal bleeding. New non-invasive tests should be examined.

Entities:  

Mesh:

Year:  2017        PMID: 28444987      PMCID: PMC6478276          DOI: 10.1002/14651858.CD008759.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  136 in total

Review 1.  Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis.

Authors:  Li Ying; Xiao Lin; Zuo-Liu Xie; Yuan-Ping Hu; Ke-Qing Shi
Journal:  Dig Dis Sci       Date:  2012-02-26       Impact factor: 3.199

2.  Derivation of a clinical prediction rule for the noninvasive diagnosis of varices in children.

Authors:  Juan Cristóbal Gana; Dan Turner; Eve A Roberts; Simon C Ling
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-02       Impact factor: 2.839

3.  Adverse events of upper GI endoscopy.

Authors:  Tamir Ben-Menachem; G Anton Decker; Dayna S Early; Jerry Evans; Robert D Fanelli; Deborah A Fisher; Laurel Fisher; Norio Fukami; Joo Ha Hwang; Steven O Ikenberry; Rajeev Jain; Terry L Jue; Khalid M Khan; Mary L Krinsky; Phyllis M Malpas; John T Maple; Ravi N Sharaf; Jason A Dominitz; Brooks D Cash
Journal:  Gastrointest Endosc       Date:  2012-10       Impact factor: 9.427

4.  Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus-related cirrhosis.

Authors:  Jing-Houng Wang; Seng-Kee Chuah; Sheng-Nan Lu; Chao-Hung Hung; Chien-Hung Chen; Kwong-Ming Kee; Kuo-Chin Chang; Wei-Chen Tai; Tsung-Hui Hu
Journal:  J Gastroenterol Hepatol       Date:  2012-07       Impact factor: 4.029

5.  Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis.

Authors:  D Lebrec; P De Fleury; B Rueff; H Nahum; J P Benhamou
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

6.  Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study.

Authors:  Giada Sebastiani; Diego Tempesta; Giovanna Fattovich; Laurent Castera; Philippe Halfon; Marc Bourliere; Franco Noventa; Paolo Angeli; Alfredo Saggioro; Alfredo Alberti
Journal:  J Hepatol       Date:  2010-06-08       Impact factor: 25.083

Review 7.  Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.

Authors:  Lise Lotte Gluud; Aleksander Krag
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

8.  Platelet count/spleen diameter ratio: analysis of its capacity as a predictor of the existence of esophageal varices.

Authors:  Angelo Zambam de Mattos; Angelo Alves de Mattos; Fernanda Farias Vianna; Maiara Isabel Musskopf; Júlio Carlos Pereira-Lima; Antônio Carlos Maciel
Journal:  Arq Gastroenterol       Date:  2010 Jul-Sep

9.  Platelet count/splenic size ratio: a parameter to predict the presence of esophageal varices in cirrhotics.

Authors:  Gul Hassan Sethar; Raeefuddin Ahmed; Suresh Kumar Rathi; Niaz A Shaikh
Journal:  J Coll Physicians Surg Pak       Date:  2006-03       Impact factor: 0.711

10.  Gamna-Gandy bodies of the spleen detected with susceptibility weighted imaging: maybe a new potential non-invasive marker of esophageal varices.

Authors:  Jiuquan Zhang; Ran Tao; Zhonglan You; Yongming Dai; Yi Fan; Jinguo Cui; Qing Mao; Jian Wang
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more
  14 in total

1.  Measurement of splenic stiffness by 2D-shear wave elastography in patients with extrahepatic portal vein obstruction.

Authors:  Kumble Seetharama Madhusudhan; Ragini Kilambi; Peush Sahni; Raju Sharma; Deep Narayan Srivastava; Arun Kumar Gupta
Journal:  Br J Radiol       Date:  2018-09-18       Impact factor: 3.039

Review 2.  Hepatic Manifestations of Cystic Fibrosis.

Authors:  Sasan Sakiani; David E Kleiner; Theo Heller; Christopher Koh
Journal:  Clin Liver Dis       Date:  2019-02-21       Impact factor: 6.126

Review 3.  Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Dan Turner; Jason Yap; Thomasin Adams-Webber; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2014-10-01

4.  Liver Ultrasound Patterns in Children With Cystic Fibrosis Correlate With Noninvasive Tests of Liver Disease.

Authors:  Simon C Ling; Wen Ye; Daniel H Leung; Oscar M Navarro; Alexander Weymann; Wikrom Karnsakul; A Jay Freeman; John C Magee; Michael R Narkewicz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

5.  Apelin Association with Hepatic Fibrosis and Esophageal Varices in Patients with Chronic Hepatitis C Virus.

Authors:  Lamyaa Abdellatif Soliman; Rania A Zayed; Dalia Omran; Fadwa Said; Samar Kamal Darweesh; Doaa Mohamed Ghaith; Rasha Eletreby; Mahmoud Salama Barakat; Mahmoud M Bendary; Doaa Zakaria Zaky; Eman Amer; Iman Rifaat Elmahgoub
Journal:  Am J Trop Med Hyg       Date:  2022-06-13       Impact factor: 3.707

Review 6.  Clinical Assessment and Management of Portal Hypertension.

Authors:  Jacob Kibrit; Ruben Khan; Barbara H Jung; Sean Koppe
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

7.  Comparison of simplified and traditional pericardial devascularisation combined with splenectomy for the treatment of portal hypertension.

Authors:  Ya-Fei Zhang; Hong Ji; Hong-Wei Lu; Le Lu; Lei Wang; Jin-Long Wang; Yi-Ming Li
Journal:  World J Clin Cases       Date:  2018-06-16       Impact factor: 1.337

Review 8.  Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma.

Authors:  Bibek Aryal; Munekazu Yamakuchi; Toshiaki Shimizu; Jun Kadono; Akira Furoi; Kentaro Gejima; Teruo Komokata; Teruto Hashiguchi; Yutaka Imoto
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-27

9.  Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension.

Authors:  Morven E Cunningham; Gilda Parastandeh-Chehr; Orlando Cerocchi; David K Wong; Keyur Patel
Journal:  Can J Gastroenterol Hepatol       Date:  2019-02-07

10.  The magnitude and correlates of esophageal Varices among newly diagnosed cirrhotic patients undergoing screening fibre optic endoscope before incident bleeding in North-Western Tanzania; a cross-sectional study.

Authors:  Daniel W Gunda; Semvua B Kilonzo; Zakhia Mamballah; Paulina M Manyiri; David C Majinge; Hyasinta Jaka; Benson R Kidenya; Humphrey D Mazigo
Journal:  BMC Gastroenterol       Date:  2019-11-29       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.